Quick Answer
TREACE MEDICAL CONCEPTS, INC. reported Total Assets of $190.58 million for the year ending 2025.
- TREACE MEDICAL CONCEPTS, INC. showed a decrease of -12.2% in Total Assets from 2024 to 2025.
- This data is from TREACE MEDICAL CONCEPTS, INC.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $37.38 million | Q2 2021: $142.30 million | Q3 2021: $137.59 million | Q1 2022: $146.51 million | Q2 2022: $158.72 million | Q3 2022: $156.44 million | Q1 2023: $249.17 million | Q2 2023: $249.64 million | Q3 2023: $240.36 million | Q1 2024: $242.73 million | Q2 2024: $226.08 million | Q3 2024: $212.92 million | Q1 2025: $205.85 million | Q2 2025: $206.44 million | Q3 2025: $196.59 million.
- Over the full 6 years of available data (2020 to 2025), TREACE MEDICAL CONCEPTS, INC.'s Total Assets has grown by 355.9%.
- Historical annual values: Fiscal year 2025: $190.58 million | Fiscal year 2024: $217.09 million | Fiscal year 2023: $251.91 million | Fiscal year 2022: $159.02 million | Fiscal year 2021: $140.82 million | Fiscal year 2020: $41.81 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: